Autoimmune hepatitis with giant-cell transformation
Journal Title: Annals of Hepatology - Year 2009, Vol 8, Issue 1
Abstract
Background/Aims: Giant-cell hepatitis (GCH), also known as postinfantile or syncytial giant cell hepatitis, is a frequent pattern of liver injury in the neonate, primarily seen in the first three months of life. Few cases in adults have been reported, some of them associated to autoimmune diseases such as autoimmune hepatitis. Methods: We present a case of autoimmune hepatitis with giant cell transformation in a 39 year old male with polyarthritis. We discuss his clinical presentation and course. We made a review of the literature of agents associated to this diagnosis, the mechanisms involved in the formation of giant hepatocytes, the histological findings, clinical course, treatment options and prognosis of this rare entity. Results and conclusions: In conclusion, the clinical course varies from normalization of hepatic histology to progression to cirrhosis and liver failure. The prognosis is dictated by the underlying liver disease and in the setting of autoimmune hepatitis the clinical course is usually severe with most of the patients progressing to cirrhosis. Prolonged treatment with corticosteroids and immunosuppressants is usually effective in rendering the cirrhosis inactive.
Authors and Affiliations
José Estradas, Virginia Pascual-Ramos;, Braulio Martínez, Misael Uribe, Aldo Torre
Keywords
Related Articles
- EP ID EP77832
- DOI -
- Views 417
- Downloads 0
Hepatic hydrothorax: Current concepts of pathophysiology and treatment options
Pleural effusions develop in 6-10% of patients with end-stage liver disease. Although, commonly seen in conjunction with ascites, isolated hepatic hydrothorax can occur in a small number of patients with cirrhosis. Refra...
Multiple Biliary Hamartomas, The ‘‘Von Meyenburg Complexes’’
-
Association between type two diabetes and non-alcoholic fatty liver disease in youth
In the last three decades prevalence of insulin related diseases has been growing worldwide with epidemic obesity, type 2 diabetes mellitus and non alcoholic fatty liver disease. In children such epidemics are particular...
Rhabdomyolysis in a hepatitis C virus infected patient treated with telaprevir and simvastatin
A 46-year old man with a chronic hepatitis C virus infection received triple therapy with ribavirin, pegylated interferon and telaprevir. The patient also received simvastatin. One month after starting the antiviral ther...
Causes of death after liver transplantation